Lexapro_pills - Volteface

/vɒlt'fæs/

Industry News
Advocacy News
Opinion
Long Reads
Reports
About
- About Volteface
- Contact us
Work with us: Volteface Strategy

88

Popular antidepressant Lexapro, more commonly known in the UK as Citalopram. (Source: Wikimedia Commons)

0 Facebook Twitter Pinterest Email

Calum Armstrong

Search

About Volteface

Volteface is an independent research and advocacy organisation, that seeks to reduce the harm drugs pose to individuals and society, through evidence-based policy reform.

Newsletter

Leave this field empty if you're human:

Categories

Advocacy News
Features
Featured
Industry News
Long Reads
Opinion
Reports

Recent Posts

Lyphe Launches V Range: Affordable, Reliable, and Future-Ready Medical Cannabis

December 20, 2024
Germany’s Cannabis Pilot Programme: A Transformative Step for Europe’s Industry

December 12, 2024
Kamala Harris’ Support for Cannabis Legalisation: What It Could Mean for the Future of US Drug Policy

October 1, 2024
Stigma and Inequality: The Hidden Harms Faced by UK Cannabis Patients

October 1, 2024
Is Ketamine Use Among Young People in the UK a Growing Crisis?

September 16, 2024

Instagram

Facebook
Twitter
Instagram
Linkedin
Youtube
Spotify
Rss
Tiktok

Home
About Volteface
Industry News
Advocacy News
Opinion
Featured
Long Reads
Reports
Work with Us: Volteface Strategy

© Copyrights 2022 VolteFace - All Right Reserved.

Industry News
Advocacy News
Opinion
Long Reads
Reports
About
- About Volteface
- Contact us
Work with us: Volteface Strategy

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept

Privacy & Cookies Policy